Ernexa Therapeutics INC. (ERNA) — SEC Filings
Latest SEC filings for Ernexa Therapeutics INC.. Recent EFFECT filing on Mar 31, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.
View Ernexa Therapeutics INC. on SEC EDGAR
Overview
Ernexa Therapeutics INC. (ERNA) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a EFFECT filed on Mar 31, 2026: Ernexia Therapeutics Inc. filed an EFFECT form on March 31, 2026, indicating the effectiveness of a registration statement. The filing, with SEC Accession No. 9999999995-26-000994, was accepted at 00:15:33. The effectiveness date is noted as March 30, 2026.
Sentiment Summary
Across 1 filings, the sentiment breakdown is: 1 neutral. The dominant filing sentiment for Ernexa Therapeutics INC. is neutral.
Filing Type Overview
Ernexa Therapeutics INC. (ERNA) has filed 1 EFFECT with the SEC between Mar 2026.
Recent Filings (1)
-
Ernexia Therapeutics Inc. Registration Statement Declared Effective
— EFFECT · Mar 31, 2026 Risk: low
Ernexia Therapeutics Inc. filed an EFFECT form on March 31, 2026, indicating the effectiveness of a registration statement. The filing, with SEC Accession No. 9
Risk Profile
Risk Assessment: Of ERNA's 1 recent filings, 0 were flagged as high-risk, 0 as medium-risk, and 1 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.
Top Tags
registration-statement (1) · effectiveness (1) · sec-filing (1)
Key Numbers
- Effectiveness Date: 2026-03-30 — The date the registration statement became effective.
- Acceptance Date: 2026-03-31 — The date the SEC accepted the filing.
Frequently Asked Questions
What are the latest SEC filings for Ernexa Therapeutics INC. (ERNA)?
Ernexa Therapeutics INC. has 1 recent SEC filings from Mar 2026, including 1 EFFECT. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of ERNA filings?
Across 1 filings, the sentiment breakdown is: 1 neutral. The dominant sentiment is neutral.
Where can I find Ernexa Therapeutics INC. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Ernexa Therapeutics INC. (ERNA) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Ernexa Therapeutics INC.?
Financial highlights for Ernexa Therapeutics INC. are available when 10-K or 10-Q filings are enriched with AI analysis. Check back as new filings are processed.
What is the investment thesis for ERNA?
Investment thesis data for ERNA will be available once enriched filings are processed.
Who are the key executives at Ernexa Therapeutics INC.?
Executive information for Ernexa Therapeutics INC. is extracted from SEC filings as they are enriched with AI analysis.
What are the main risk factors for Ernexa Therapeutics INC. stock?
Of ERNA's 1 assessed filings, 0 were flagged high-risk, 0 medium-risk, and 1 low-risk.
What are recent predictions and forward guidance from Ernexa Therapeutics INC.?
Forward guidance and predictions for Ernexa Therapeutics INC. are extracted from SEC filings as they are enriched.